Interferon alfa-2b

From WikiMD's WELLNESSPEDIA

(Redirected from Interferon alpha-2b)

Type of medication

Interferon alfa-2b

Interferon alfa-2b


Trade names Intron A





Routes Intramuscular, subcutaneous, intravenous
Pregnancy category C



Half-life 2-3 hours
Excretion Renal
Legal status Rx-only
Identifiers
CAS Number 99210-65-8
PubChem 135346
DrugBank DB00011


UNII PDC6A3C0OX
KEGG D00743
ChEMBL 1201588









Interferon alfa-2b is a recombinant protein used in the treatment of various viral infections and cancer. It is a type of interferon, which are proteins made and released by host cells in response to the presence of pathogens such as viruses, bacteria, parasites, and tumor cells. Interferon alfa-2b is produced using recombinant DNA technology and is marketed under the brand name Intron A.

Medical uses[edit]

Interferon alfa-2b is used to treat a variety of conditions, including:

Mechanism of action[edit]

Interferon alfa-2b works by binding to specific receptors on the surface of cells, initiating a complex signaling pathway that leads to the expression of numerous genes. These genes are involved in:

  • Inhibiting viral replication
  • Enhancing the immune response
  • Inhibiting cell proliferation
  • Inducing apoptosis (programmed cell death)

Administration[edit]

Interferon alfa-2b can be administered via several routes, including:

Side effects[edit]

Common side effects of interferon alfa-2b include:

History[edit]

Interferon alfa-2b was one of the first recombinant proteins to be approved for medical use. It was developed in the 1980s and has since been used to treat millions of patients worldwide.

See also[edit]

Related pages[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.